This page is part of the FHIR Specification (v4.3.0: R4B - STU). The current version which supercedes this version is 5.0.0. For a full list of available versions, see the Directory of published versions . Page versions: R5 R4B
Biomedical Research and Regulation Work Group | Maturity Level: N/A | Standards Status: Informative |
Raw XML (canonical form + also see XML Format Specification)
Definition for Code SystemSubstanceGrade
<?xml version="1.0" encoding="UTF-8"?> <CodeSystem xmlns="http://hl7.org/fhir"> <id value="substance-grade"/> <meta> <lastUpdated value="2022-05-28T13:47:40.239+11:00"/> <profile value="http://hl7.org/fhir/StructureDefinition/shareablecodesystem"/> </meta> <text> <status value="generated"/> <div xmlns="http://www.w3.org/1999/xhtml"> <p> This code system http://hl7.org/fhir/substance-grade defines the following codes:</p> <table class="codes"> <tr> <td style="white-space:nowrap"> <b> Code</b> </td> <td> <b> Display</b> </td> </tr> <tr> <td style="white-space:nowrap">USP-NF <a name="substance-grade-USP-NF"> </a> </td> <td> USP/NF United States Pharmacopeia (USP) and the National Formulary (NF)</td> </tr> <tr> <td style="white-space:nowrap">Ph.Eur <a name="substance-grade-Ph.46Eur"> </a> </td> <td> European Pharmacopoeia</td> </tr> <tr> <td style="white-space:nowrap">JP <a name="substance-grade-JP"> </a> </td> <td> Japanese Pharmacopoeia</td> </tr> <tr> <td style="white-space:nowrap">BP <a name="substance-grade-BP"> </a> </td> <td> British Pharmacopoeia</td> </tr> <tr> <td style="white-space:nowrap">CompanyStandard <a name="substance-grade-CompanyStandard"> </a> </td> <td> Company Standard</td> </tr> </table> </div> </text> <extension url="http://hl7.org/fhir/StructureDefinition/structuredefinition-wg"> <valueCode value="brr"/> </extension> <extension url="http://hl7.org/fhir/StructureDefinition/structuredefinition-standards-status"> <valueCode value="trial-use"/> </extension> <extension url="http://hl7.org/fhir/StructureDefinition/structuredefinition-fmm"> <valueInteger value="1"/> </extension> <url value="http://hl7.org/fhir/substance-grade"/> <identifier> <system value="urn:ietf:rfc:3986"/> <value value="urn:oid:2.16.840.1.113883.4.642.1.1609"/> </identifier> <version value="4.3.0"/> <name value="SubstanceGrade"/> <title value="SubstanceGrade"/> <status value="draft"/> <experimental value="false"/> <date value="2021-01-05T10:01:24+11:00"/> <publisher value="HL7 (FHIR Project)"/> <contact> <telecom> <system value="url"/> <value value="http://hl7.org/fhir"/> </telecom> <telecom> <system value="email"/> <value value="fhir@lists.hl7.org"/> </telecom> </contact> <caseSensitive value="true"/> <valueSet value="http://hl7.org/fhir/ValueSet/substance-grade"/> <content value="complete"/> <concept> <code value="USP-NF"/> <display value="USP/NF United States Pharmacopeia (USP) and the National Formulary (NF)"/> </concept> <concept> <code value="Ph.Eur"/> <display value="European Pharmacopoeia"/> </concept> <concept> <code value="JP"/> <display value="Japanese Pharmacopoeia"/> </concept> <concept> <code value="BP"/> <display value="British Pharmacopoeia"/> </concept> <concept> <code value="CompanyStandard"/> <display value="Company Standard"/> </concept> </CodeSystem>
Usage note: every effort has been made to ensure that the examples are correct and useful, but they are not a normative part of the specification.